Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.
about
Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injuryDevelopments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions.Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma.Regulation of circulating sclerostin levels by sex steroids in women and in men.The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft modelNELL-1 in the treatment of osteoporotic bone loss.Update on Wnt signaling in bone cell biology and bone disease.p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction.Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA PathwayssFRP4-dependent Wnt signal modulation is critical for bone remodeling during postnatal development and age-related bone lossWnt and Wnt inhibitors in bone metastasis.The osteocyte: an endocrine cell ... and more.CathepsinKCre mediated deletion of βcatenin results in dramatic loss of bone mass by targeting both osteoclasts and osteoblastic cells.Role of Wnt/β-catenin pathway in inducing autophagy and apoptosis in multiple myeloma cells.Proteasome inhibitors and bone disease.Systemic effects of Wnt signaling.Fact or fiction--identifying the elusive multiple myeloma stem cell.Emerging therapeutic targets for osteoporosis treatment.Wnt/β-catenin signaling in bone marrow niche.In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma.Bone resorption following weight loss surgery is associated with treatment procedure and changes in secreted Wnt antagonists.Expression of Wnt3a in hepatocellular carcinoma and its effects on cell cycle and metastasis.Antagonists of Wnt/β-catenin signalling in the periodontitis associated with type 2 diabetes and smoking.RhPDCD5 combined with dexamethasone increases antitumor activity in multiple myeloma partially via inhibiting the Wnt signalling pathway.Phospholipase Cγ1 (PLCγ1) Controls Osteoclast Numbers via Colony-stimulating Factor 1 (CSF-1)-dependent Diacylglycerol/β-Catenin/CyclinD1 Pathway.
P2860
Q28584092-9FF6C2AD-6791-42EF-AA19-2B4FA20A0EBAQ33564617-FD9C89FC-2F46-44A0-AFD9-0CBEAE7A3B00Q34997270-FC1A88BD-FEA7-44AF-A7E5-53809004B5D2Q35094024-15ACAE10-887D-4CF0-97D9-D9D0CABCE6A3Q35860566-D923B13E-9CC4-4F83-8334-0671E05CC5FDQ35868347-97BA3534-0873-4D3D-A7F9-ADD306A97690Q36018565-1182525B-8258-4AA5-8019-EBB80EA23CCAQ36083303-3C9B160C-D84D-4E69-AEE8-8AF406A578C6Q36476432-51AE2290-E4C0-4AFC-9800-34E850A5D399Q36593417-C4493CFC-00AA-4620-B64A-C2B3B96C9C7DQ36841079-59DD31F9-9DE6-43C9-903B-8297F0FD8CD6Q37056355-E75B37E2-4C4E-411F-BE68-411C59D2BF94Q37203605-50655B4F-CF9E-4C2B-8B69-B69BF7E29308Q37386387-6A7605FC-7E2F-46FA-BF64-508EA41C8CC0Q37582380-689C381A-1292-4C69-9C03-A3D139BD8A7BQ38021042-799AEEC4-91BB-4401-AB32-8D8C11305094Q38077507-A4B5E0F3-6868-465C-A467-F8DF8E99BBBCQ38169258-90F79EEF-37E6-406F-931E-98069AA0DA9BQ38207147-C7D91C96-6CD1-4906-8755-C423A8D296A3Q38609596-648C3EBB-1582-4D19-A401-5D32ED8E3DC6Q39208071-7C8BAD25-9BEE-4EF1-B926-958F0FB77FFEQ39937522-3CF2BF37-DC03-4C18-AF9B-DF1211349AD8Q41387500-19FC2499-9AA4-4C48-ABDE-8DE4FD3E8F96Q47291173-AB630483-2F2A-4986-933C-61E00FFA78B9Q47747256-A121E8B3-986A-49A1-8923-CB5E5133F003Q50287392-72CBBBC3-0C7F-4C5C-993F-3C45610A3A76
P2860
Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.
@en
type
label
Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.
@en
prefLabel
Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.
@en
P2093
P2860
P1476
Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.
@en
P2093
John D Shaughnessy
Joshua Epstein
Nathan Brown
Ya-Wei Qiang
P2860
P304
P356
10.1111/J.1365-2141.2009.08009.X
P407
P577
2009-11-24T00:00:00Z